AI assistant
Sending…
Aptevo Therapeutics Inc. — Director's Dealing 2019
Aug 19, 2019
35422_dirs_2019-08-19_1b552bd7-d091-4375-9cbf-563a36290714.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Aptevo Therapeutics Inc. (APVO)
CIK: 0001671584
Period of Report: 2019-08-16
Reporting Person: Maddux Randy Joe (SVP Operations, CMO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-08-16 | Common Stock | P | 25000 | $0.76 | Acquired | 75000 | Direct |
More from Aptevo Therapeutics Inc.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Mar 27
Declaration of Voting Results & Voting Rights Announcements
2026
Feb 19
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Board/Management Information
2026
Feb 3
Capital/Financing Update
2026
Jan 30
Capital/Financing Update
2026
Jan 28
Proxy Solicitation & Information Statement
2026
Jan 26